182 related articles for article (PubMed ID: 32418527)
1. Anti-Candida Activity of Curcumin: A Systematic Review.
Cheraghipour K; Ezatpour B; Masoori L; Marzban A; Sepahvand A; Rouzbahani AK; Moridnia A; Khanizadeh S; Mahmoudvand H
Curr Drug Discov Technol; 2021; 18(3):379-390. PubMed ID: 32418527
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis.
Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M
Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431
[TBL] [Abstract][Full Text] [Related]
3. New weapons to fight a new enemy: A systematic review of drug combinations against the drug-resistant fungus Candida auris.
Aghaei Gharehbolagh S; Izadi A; Talebi M; Sadeghi F; Zarrinnia A; Zarei F; Darmiani K; Borman AM; Mahmoudi S
Mycoses; 2021 Nov; 64(11):1308-1316. PubMed ID: 33774879
[TBL] [Abstract][Full Text] [Related]
4. Exploration of Medicinal Plants as Sources of Novel Anticandidal Drugs.
Kumar A; Khan F; Saikia D
Curr Top Med Chem; 2019; 19(28):2579-2592. PubMed ID: 31654513
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antifungal effects of curcumin derivatives as fungal biofilm inhibitors with fluconazole.
Dong HH; Wang YH; Peng XM; Zhou HY; Zhao F; Jiang YY; Zhang DZ; Jin YS
Chem Biol Drug Des; 2021 May; 97(5):1079-1088. PubMed ID: 33506609
[TBL] [Abstract][Full Text] [Related]
6. The use of nanoparticles as alternative therapeutic agents against Candida infections: an up-to-date overview and future perspectives.
Mba IE; Nweze EI
World J Microbiol Biotechnol; 2020 Sep; 36(11):163. PubMed ID: 32990838
[TBL] [Abstract][Full Text] [Related]
7. Impact of new antifungal breakpoints on antifungal resistance in Candida species.
Fothergill AW; Sutton DA; McCarthy DI; Wiederhold NP
J Clin Microbiol; 2014 Mar; 52(3):994-7. PubMed ID: 24403302
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of curcumin in the treatment of experimental vulvovaginal candidiasis.
Andrade JT; Fantini de Figueiredo G; Cruz LF; Eliza de Morais S; Souza CDF; Pinto FCH; Ferreira JMS; Araújo MGF
Rev Iberoam Micol; 2019; 36(4):192-199. PubMed ID: 31757595
[TBL] [Abstract][Full Text] [Related]
9. Molecular Typing and Antifungal Susceptibility of Candida viswanathii, India.
Shankarnarayan SA; Rudramurthy SM; Chakrabarti A; Shaw D; Paul S; Sethuraman N; Kaur H; Ghosh AK
Emerg Infect Dis; 2018 Oct; 24(10):1956-1958. PubMed ID: 30226183
[TBL] [Abstract][Full Text] [Related]
10. Antifungal Properties of
Shafaroudi AM; Gorji NE; Nasiri P; Javidnia J; Saravi ME
J Evid Based Integr Med; 2022; 27():2515690X221132272. PubMed ID: 36423242
[TBL] [Abstract][Full Text] [Related]
11. Potent in vitro activity of curcumin and quercetin co-encapsulated in nanovesicles without hyaluronan against Aspergillus and Candida isolates.
Sadeghi-Ghadi Z; Vaezi A; Ahangarkani F; Ilkit M; Ebrahimnejad P; Badali H
J Mycol Med; 2020 Dec; 30(4):101014. PubMed ID: 32800427
[TBL] [Abstract][Full Text] [Related]
12. A Paradigm Shift in the Development of Anti-Candida Drugs.
Gowda DV; Afrasim M; Meenakshi SI; Manohar M; Hemalatha S; Siddaramaiah H; Sathishbabu P; Rizvi SMD; Hussain T; Kamal MA
Curr Top Med Chem; 2019; 19(28):2610-2628. PubMed ID: 31663480
[TBL] [Abstract][Full Text] [Related]
13. Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans.
Sharma M; Manoharlal R; Puri N; Prasad R
Biosci Rep; 2010 Dec; 30(6):391-404. PubMed ID: 20017731
[TBL] [Abstract][Full Text] [Related]
14. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological advances in the treatment of invasive candidiasis.
Deck DH; Guglielmo BJ
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Phytomedicines and Novel Polymeric Strategies for Significant Management of Candidiasis.
Rohilla S; Bhatt DC; Gupta A
Curr Pharm Des; 2018; 24(16):1748-1765. PubMed ID: 29792138
[TBL] [Abstract][Full Text] [Related]
17. In vitro antifungal activity of cassia fistula extracts against fluconazole resistant strains of Candida species from HIV patients.
Sony P; Kalyani M; Jeyakumari D; Kannan I; Sukumar RG
J Mycol Med; 2018 Mar; 28(1):193-200. PubMed ID: 28838629
[TBL] [Abstract][Full Text] [Related]
18. Antifungal activity of oils macerates of North Sardinia plants against
Donadu MG; Usai D; Marchetti M; Usai M; Mazzarello V; Molicotti P; Montesu MA; Delogu G; Zanetti S
Nat Prod Res; 2020 Nov; 34(22):3280-3284. PubMed ID: 30676066
[TBL] [Abstract][Full Text] [Related]
19. Impact of real-time fungal susceptibility on clinical practices.
Magiorakos AP; Hadley S
Curr Opin Infect Dis; 2004 Dec; 17(6):511-5. PubMed ID: 15640704
[TBL] [Abstract][Full Text] [Related]
20. Azole derivatives with naphthalene showing potent antifungal effects against planktonic and biofilm forms of Candida spp.: an in vitro and in silico study.
Sari S; Koçak E; Kart D; Özdemir Z; Acar MF; Sayoğlu B; Karakurt A; Dalkara S
Int Microbiol; 2021 Jan; 24(1):93-102. PubMed ID: 32889579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
